Dr Jennifer Anne Freimund, MD | |
1450 Chapel St Ste 107, New Haven, CT 06511-4405 | |
(310) 663-6162 | |
Not Available |
Full Name | Dr Jennifer Anne Freimund |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 1450 Chapel St Ste 107, New Haven, Connecticut |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003113762 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363A00000X | Physician Assistant | PA21430 (California) | Secondary |
207RG0300X | Internal Medicine - Geriatric Medicine | 63896 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Jennifer Anne Freimund, MD Po Box 6371, Hamden, CT 06517-0371 Ph: (203) 823-8625 | Dr Jennifer Anne Freimund, MD 1450 Chapel St Ste 107, New Haven, CT 06511-4405 Ph: (310) 663-6162 |
News Archive
Manufacturers temperature controlled microscopy, Linkam Scientific Instruments, have been chosen by the Physics Department of the University of Liverpool to study the effects of controlling stresses applied during the growth of collagen secreted from human fibroblast cells. The research goal of Senior Research Assistant, Dr Caroline Smith, and her colleagues at the University of Liverpool is to advance the treatment of tendon injuries by developing a method of growing oriented human collagen.
As a wide variety of nanoparticles continue to demonstrate their ability to improve the delivery of imaging agents and drugs to tumors, nanoparticle researchers have turned their attention to the challenge of systematically determining how a given nanoparticle's physical and chemical characteristics affect its ability to target tumors. Such data could provide drug developers with guidelines to help them select the most effective type of nanoparticle for a given therapeutic or imaging application.
Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, announced today that its Board of Directors adopted a Stockholder Rights Plan. The rights plan is designed to discourage coercive or unfair takeover tactics and to provide fair and equal treatment for all stockholders of the Company in the event that an unsolicited offer is made to acquire the Company.
The report Smoking and Health: Report of the Advisory Committee to the Surgeon General, identified tobacco as the predominant cause of lung cancer in men. This was the first widely disseminated report based on scientific studies showing the clear link between smoking tobacco and serious health conditions including cancer, chronic lung diseases and heart disease.
The US National Institutes of Health (NIH) has awarded a $2.1 million "Grand Opportunity" (GO) grant to a team of researchers - led by Prof. Todd Lencz at the Feinstein Institute for Medical Research, New York, and Prof.Ariel Darvasi of the Silberman Institute of Life Sciences at the Hebrew University of Jerusalem - to conduct a study on the genetic basis of schizophrenia..
› Verified 3 days ago